Medication Adherence, Rejection, Self Management
Conditions
Brief summary
Medication-related non-adherence increases the risk of rejections and associated graft loss after solid organ transplantation. A randomized controlled intervention will use adherence enhancing strategies out of a larger sample of 300 heart transplant recipients. Non-Adherence will be assessed by patients' self-report and based on immunosuppression level. All non-adherent patients will be randomly designed to either intervention or control group. Multi-module interventions include patient education, electronic medication event monitoring, and a combined behavior and symptom management. Longitudinal follow-up is envisioned after initial intervention.
Interventions
behavioral adaptation and symptom management
Sponsors
Study design
Eligibility
Inclusion criteria
* all eligible patients with follow-up at our outpatient clinic * written informed consent * sufficient German language skills to read and answer a battery of questionnaires * \> 18 years * minimum 6 mts post HTX
Exclusion criteria
* illiteracy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events (composite endpoint) | at month 60 |
Secondary
| Measure | Time frame |
|---|---|
| Adherence behavior measurement variables from MEMS system | first 3 month |
| Immunosuppression level | Month 3, 12 and 60 |
| All individual components of the composite endpoint occurence of adverse events | at month 60 |
Countries
Germany